Orth M, Rasche K, Ullrich H U, Duchna H W, Schultze-Werninghaus G
Berufsgenossenschaftliche Kliniken Bergmannsheil, Universitätsklinik, Ruhr-Universität Bochum.
Pneumologie. 1995 Mar;49 Suppl 1:212-5.
The therapeutic effect in application of n-CPAP therapy (nasal continuous positive airway pressure) is dependent on both the acute effect of this therapy and the long-term acceptance and consequent palliation respectively avoidance of sequelae. We present 50 patients (47 male, 3 female) treated with n-CPAP therapy because of severe sleep-related disorders of breathing. All patients had polysomnography, and in addition questionnaires were mailed to all 50 patients in order to get information concerning the symptoms of sleep-related disorders of breathing before and under n-CPAP therapy, mode of therapy and side-effects in application of n-CPAP therapy. Patients were treated for at least three to a maximum of 25 months with n-CPAP (average 10.5 months). Long-term acceptance with n-CPAP was defined as persistent use of n-CPAP during every night for at least five hours. On average continuous positive airway pressure of 8.6 mbar (range 4-18) was effective in normalizing formerly severe pathological respiratory parameters. Apnea-index decreased from 22.8 to 2.17/h on average. Regarding the symptoms of sleep-related disorders of breathing before and under n-CPAP therapy, we saw that almost 100% of our patients complained of the main symptoms of sleep-related disorders of breathing. By regular n-CPAP application a complete reduction of these symptoms could be achieved in nearly 80% of patients. Long-term acceptance of n-CPAP therapy was reported by 78% of our patients who used their n-CPAP device every night for at least five hours.(ABSTRACT TRUNCATED AT 250 WORDS)
应用鼻持续气道正压通气(n-CPAP)治疗的疗效取决于该治疗的急性效果以及长期接受度,进而缓解症状并分别避免后遗症。我们介绍了50例(47例男性,3例女性)因严重睡眠相关呼吸障碍接受n-CPAP治疗的患者。所有患者均进行了多导睡眠图检查,此外还向所有50例患者邮寄了问卷,以获取有关n-CPAP治疗前和治疗期间睡眠相关呼吸障碍症状、治疗方式以及n-CPAP治疗副作用的信息。患者接受n-CPAP治疗至少3个月至最长25个月(平均10.5个月)。n-CPAP的长期接受度定义为每晚持续使用n-CPAP至少5小时。平均8.6毫巴(范围4 - 18)的持续气道正压通气可有效使先前严重的病理呼吸参数恢复正常。呼吸暂停指数平均从22.8降至2.17次/小时。关于n-CPAP治疗前和治疗期间睡眠相关呼吸障碍的症状,我们发现几乎100%的患者抱怨有睡眠相关呼吸障碍的主要症状。通过定期应用n-CPAP,近80%的患者可完全缓解这些症状。我们78%的患者报告长期接受n-CPAP治疗,他们每晚使用n-CPAP设备至少5小时。(摘要截选至250字)